Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22823 | 311 | 27.3 | 52% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VINPOCETINE | Author keyword | 52 | 51% | 23% | 72 |
2 | VA 045 | Author keyword | 21 | 85% | 4% | 11 |
3 | CAS 42971 09 5 | Author keyword | 12 | 86% | 2% | 6 |
4 | APOVINCAMINIC ACID | Author keyword | 10 | 73% | 3% | 8 |
5 | CAVINTON | Author keyword | 5 | 47% | 3% | 8 |
6 | VINCAMINE | Author keyword | 5 | 38% | 3% | 10 |
7 | HOMOEXCHANGE | Author keyword | 2 | 67% | 1% | 2 |
8 | INVEST BASICA LICADA | Address | 2 | 67% | 1% | 2 |
9 | OOCYTES XENOPUS | Author keyword | 2 | 67% | 1% | 2 |
10 | VINPOTROPIL | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VINPOCETINE | 52 | 51% | 23% | 72 | Search VINPOCETINE | Search VINPOCETINE |
2 | VA 045 | 21 | 85% | 4% | 11 | Search VA+045 | Search VA+045 |
3 | CAS 42971 09 5 | 12 | 86% | 2% | 6 | Search CAS+42971+09+5 | Search CAS+42971+09+5 |
4 | APOVINCAMINIC ACID | 10 | 73% | 3% | 8 | Search APOVINCAMINIC+ACID | Search APOVINCAMINIC+ACID |
5 | CAVINTON | 5 | 47% | 3% | 8 | Search CAVINTON | Search CAVINTON |
6 | VINCAMINE | 5 | 38% | 3% | 10 | Search VINCAMINE | Search VINCAMINE |
7 | HOMOEXCHANGE | 2 | 67% | 1% | 2 | Search HOMOEXCHANGE | Search HOMOEXCHANGE |
8 | OOCYTES XENOPUS | 2 | 67% | 1% | 2 | Search OOCYTES+XENOPUS | Search OOCYTES+XENOPUS |
9 | VINPOTROPIL | 2 | 67% | 1% | 2 | Search VINPOTROPIL | Search VINPOTROPIL |
10 | VINCAMINIC ACID | 1 | 100% | 1% | 2 | Search VINCAMINIC+ACID | Search VINCAMINIC+ACID |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ETHYL APOVINCAMINATE | 25 | 77% | 5% | 17 |
2 | VINPOCETINE | 14 | 38% | 9% | 28 |
3 | APOVINCAMINIC ACID | 10 | 63% | 3% | 10 |
4 | BRAIN PRESYNAPTIC SODIUM | 3 | 100% | 1% | 3 |
5 | CAVINTON | 3 | 100% | 1% | 3 |
6 | H 3 GABA | 3 | 24% | 4% | 11 |
7 | NEUROPROTECTIVE DRUG VINPOCETINE | 3 | 60% | 1% | 3 |
8 | BUTYRIC ACID RELEASE | 1 | 50% | 1% | 2 |
9 | ALZHEIMER TYPES | 1 | 50% | 0% | 1 |
10 | NAFRONYL | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Role of vinpocetine in cerebrovascular diseases | 2011 | 17 | 49 | 73% |
Eburnamine derivatives and the brain | 2005 | 33 | 68 | 60% |
Role of sodium channel inhibition in neuroprotection: Effect of vinpocetine | 2000 | 56 | 83 | 41% |
Vinpocetine for acute ischaemic stroke | 2008 | 5 | 42 | 62% |
VINPOCETIN IN NEUROLOGICAL DISEASES | 2012 | 2 | 36 | 56% |
A systematic review of vinpocetine therapy in acute ischaemic stroke | 1999 | 16 | 13 | 62% |
Alternative medicine and Alzheimer disease | 2008 | 27 | 57 | 12% |
Current possibilities of the correction of oxidative stress in acute brain ischemia | 2012 | 0 | 21 | 43% |
Cavinton administration in hypertensive encephalopathy | 2008 | 0 | 49 | 47% |
PHARMACOKINETICS AND METABOLISM OF VINCAMINE AND RELATED-COMPOUNDS | 1985 | 23 | 6 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INVEST BASICA LICADA | 2 | 67% | 0.6% | 2 |
2 | CENT NUCL MED | 1 | 40% | 0.6% | 2 |
3 | CHAIR NERVOUS DIS NEUROSURG | 1 | 50% | 0.3% | 1 |
4 | CONSCI | 1 | 50% | 0.3% | 1 |
5 | INVEST BIOMED BIOL CELULAR | 1 | 50% | 0.3% | 1 |
6 | SZ BELGYOGYASZATI KLIN 1 | 1 | 50% | 0.3% | 1 |
7 | BASIC MED SCI BIOPHYS | 0 | 33% | 0.3% | 1 |
8 | BASIC MED SCI NEUROBIOL | 0 | 33% | 0.3% | 1 |
9 | CARAS | 0 | 33% | 0.3% | 1 |
10 | EXPT INVEST | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189058 | NEFIRACETAM//DM 9384//ANIRACETAM |
2 | 0.0000144108 | AUDITORY DISTURBANCE//PERIPHERAL NEUROMUSCULAR FUNCTION//ACUTE FORM |
3 | 0.0000138501 | BIFEMELANE HYDROCHLORIDE//BIFEMELANE//INDELOXAZINE HYDROCHLORIDE |
4 | 0.0000107963 | NOOPEPT//CYCLOPROLYLGLYCINE//GVS 111 |
5 | 0.0000090877 | GLUTAMATE EXOCYTOSIS//CEREBROCORTICAL SYNAPTOSOME//CEREBROCORTICAL SYNAPTOSOMES |
6 | 0.0000067632 | NICERGOLINE//SERMION//CAS 27848 84 6 |
7 | 0.0000062643 | CLOMETHIAZOLE//CHLORMETHIAZOLE//CHLOMETHIAZOLE |
8 | 0.0000059739 | BRAIN NEUROCHEMICAL RESPONSES//GASTROINTESTINAL STASIS//THIOPENTAL COMA |
9 | 0.0000054965 | TACTIVIN//AMIRIDIN//CADDIES |
10 | 0.0000044994 | NAFTIDROFURYL//NEBRACETAM//MICROSPHERE EMBOLISM |